The global Genetic Engineering Market is experiencing strong expansion as advances in gene editing technologies, increasing chronic disease prevalence, and changing healthcare needs create new opportunities across biotechnology and life sciences.
The Genetic Engineering Market was valued at 3982.57 million in 2024 and is expected to reach 9196.67 million by 2031. The market is anticipated to...
The Global Nucleotide Market is expanding as demand increases across pharmaceuticals, biotechnology, food and beverages, animal nutrition, and molecular biology applications. Nucleotides are essential biological molecules that form the building blocks of DNA and RNA. They also play important roles in cellular energy transfer, metabolism, and genetic information storage. Their growing use in...
The Global Nucleic Acid Isolation and Purification Market is experiencing steady expansion as molecular biology, genomics, biotechnology, and clinical diagnostics continue to advance. Nucleic acid isolation and purification are essential laboratory processes used to extract DNA and RNA from biological samples while removing contaminants that may interfere with downstream applications. These...
Laboratories and manufacturers need solvents that behave predictably. The Acetonitrile Market benefits from that need, growing from US$ 236.18 Million in 2018 towards US$ 368.60 Million by 2027. The forecast 5.1% CAGR between 2019 and 2027 shows how much consistency matters to buyers.
What Is Driving the Market?
Pharmaceuticals come first. Acetonitrile is a core solvent for drug makers. It...
The global Fibrinogen Market is witnessing significant expansion as demand increases for fibrinogen-related testing and blood coagulation solutions across healthcare settings. The market was valued at US$ 1.08 billion in 2025 and is projected to reach US$ 3.41 billion by 2034, registering a CAGR of 13.63% during 2026–2034. The market growth is associated with the rising incidence of...
The global epigenetics market is experiencing significant growth as advancements in genomic research, increasing cancer prevalence, and the expanding adoption of personalized medicine create new opportunities across healthcare and biotechnology industries. The epigenetics market size is projected to reach US$ 35.84 billion by 2031 from US$ 11.12 billion in 2024. The market is expected to...
The Global Longevity Market was valued at US$ 6.23 billion in 2025 and is expected to reach US$ 19.25 billion by 2034. The market is estimated to record a compound annual growth rate of 13.35% during 2026–2034. Increasing interest in healthy aging, rising investments in biotechnology research, and advancements in regenerative medicine are creating significant opportunities for companies...
The Global Non-invasive Prenatal Testing Market size is expected to reach US$ 14.48 billion by 2031. The market is anticipated to register a CAGR of 13.2% during 2025–2031. Increasing awareness of prenatal screening, rising maternal age, growing preference for non-invasive diagnostic procedures, and advancements in genomic technologies are supporting market expansion. Non-invasive...
The Global NGS Sample Preparation Market is expected to reach US$ 6,059 million by 2031. The market is anticipated to register a CAGR of 12.3% during 2025–2031. Increasing adoption of next-generation sequencing (NGS) technologies, growing demand for precision medicine, rising genomic research activities, and advancements in molecular diagnostics are driving market expansion. NGS sample...
The Gemcitabine Hydrochloride market was valued at US$ 873.1 million in 2025 and is expected to reach US$ 1,297.83 million by 2034. The market is estimated to record a CAGR of 4.5% during 2026–2034. The increasing prevalence of cancer, rising demand for effective chemotherapy medications, growing awareness of early cancer diagnosis, and expanding access to oncology treatments are among...
The Global Genetic Toxicology Testing Market was valued at US$ 1.59 billion in 2025 and is expected to reach US$ 4.01 billion by 2034, registering a compound annual growth rate (CAGR) of 10.83% during 2026–2034. Increasing pharmaceutical research and development activities, stricter chemical safety requirements, and growing demand for reliable genetic damage assessment are supporting the...
The Bioinformatics industry in North America is witnessing steady growth as pharmaceutical companies and academic institutions invest heavily in data-driven drug discovery and precision medicine.
The bioinformatics market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is estimated to grow at a CAGR of 15.7% from 2022 to 2028.
Key Factors Driving...